has an impeccable reputation for excellent customer services and extremely ethical and high quality of work under the leadership of Dr Pipasha Biswas
Dr Pipasha Biswas
Dr. Pipasha Biswas is currently Principal Consultant, Director & QPPV of Symogen Ltd.
has been involved in pharmacovigilance & pharmacoepidemiology for the last 18 years in Europe, USA and India.
-- More Info --
Dr. Pipasha Biswas has worked in a number of MNCs in Pharmacovigilance as Executive Director and Lead for Safety Signal detection at Global Drug Safety at Amgen Inc based in California, where she lead the safety signal detection team in global safety.
In the UK, she worked as Director, Safety Evaluation and Risk Management, Global Clinical Safety and Pharmacovigilance at GSK, London, where she was the lead physician responsible for Respiratory and Anti-inflammatory therapeutic area.
Prior to working at GSK, she was EU Senior Pharmacovigilance Physician at the European Office of Global Safety Surveillance and Epidemiology at Wyeth Europa, based in the UK.
Before moving to the pharmaceutical industry, she was Clinical Research Fellow at the Drug Safety Research Unit, based in Southampton, where she conducted large studies in post marketing surveillance.
She also has considerable experience in Clinical Research and Clinical Drug Development, having worked at the Department of Vascular Medicine, King's College of Medicine & Dentistry, where she was responsible for conducting clinical trials in Deep Vein Thrombosis patients from phase II to III.
qualified in Medicine from India and trained in Internal Medicine & Cardiology and did her
post graduation in Pharmaceutical Medicine, from University of Surrey, UK
then specialized in Pharmacovigilance & Pharmacoepidemiology
from London School of Hygiene and Tropical Medicine, London
and then did her
DM in Pharmacoepidemiology from University of Southampton, UK
She is the Member of British Association of Research and Quality Assurance (BARQA), International Society of Pharmacovigilance (ISOP) and International Society of Pharmacoepidemiology (ISPE).
has been conferred with the Membership of The Faculty of Pharmaceutical Medicine (Distinction), UK from The Faculty of Pharmaceutical Medicine, The Royal College of Physicians, London
She is the member of the International Committee and Professional Standards Committee at the Faculty of Pharmaceutical Medicine of The Royal College of Physicians, London.